Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
895.02M | 794.04M | 546.26M | 144.03M | 120.92M | Gross Profit |
132.89M | 90.23M | 83.57M | 8.45M | -18.31M | EBIT |
78.06M | 54.17M | 15.14M | -52.06M | -265.00M | EBITDA |
111.18M | 42.42M | 37.49M | -32.14M | -246.62M | Net Income Common Stockholders |
72.86M | -2.97M | 53.16M | -68.52M | -280.49M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
57.44M | 27.70M | 32.06M | 30.94M | 41.55M | Total Assets |
746.42M | 706.14M | 717.43M | 688.87M | 702.28M | Total Debt |
112.74M | 170.63M | 227.13M | 230.46M | 229.43M | Net Debt |
55.30M | 142.92M | 195.06M | 199.52M | 187.88M | Total Liabilities |
191.93M | 272.07M | 351.63M | 394.96M | 276.75M | Stockholders Equity |
554.50M | 434.07M | 365.81M | 293.90M | 425.53M |
Cash Flow | Free Cash Flow | |||
72.06M | 57.96M | 19.94M | -37.97M | -38.68M | Operating Cash Flow |
78.80M | 63.38M | 24.76M | -35.10M | -36.55M | Investing Cash Flow |
-6.74M | -5.42M | -4.83M | -2.87M | -2.13M | Financing Cash Flow |
-42.21M | -62.66M | -18.72M | 27.47M | 68.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $56.01B | 19.03 | 46.85% | 0.90% | 18.60% | 65.95% | |
74 Outperform | $1.65B | 22.71 | 14.74% | 0.76% | 12.72% | ― | |
71 Outperform | $674.68M | 9.77 | 17.85% | ― | -31.46% | -56.72% | |
66 Neutral | $25.15B | 13.33 | 25.87% | ― | 12.66% | 403.58% | |
63 Neutral | $3.47B | 81.11 | 2.43% | ― | 25.21% | -83.25% | |
59 Neutral | $2.18B | 11.18 | 9.04% | 5.47% | 5.08% | -10.62% | |
59 Neutral | $12.18B | 11.09 | -1.08% | 3.77% | 1.26% | -19.82% |
On March 17, 2025, OneSpaWorld Holdings announced leadership changes with Stephen B. Lazarus appointed as President while retaining his roles as Chief Financial Officer and Chief Operating Officer until a new CFO is appointed. Leonard Fluxman will continue as CEO and Executive Chairman, and Susan Bonner will step down as Chief Commercial Officer. These transitions highlight the company’s focus on leadership development and its commitment to maintaining its strong market position and growth trajectory in the health and wellness industry.